Can I get it?
Yes, if a doctor decides it is right for you. Wegovy is authorised in the EU and can be prescribed after a medical review.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in Spain. Consultation €25/month, refunded if the doctor decides it is not safe to prescribe.

Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
Wegovy (semaglutide) is a once-weekly injection for weight management. It copies GLP-1, a gut hormone that signals fullness to your brain and slows how quickly your stomach empties. It is authorised across the EU and is prescribed by licensed doctors when clinically appropriate.
Wegovy has been authorised for use in the EU since 6 January 2022, so a licensed doctor can prescribe it when it is clinically appropriate for you.
Learn more about peptides at Peptidepedia.
Yes, if a doctor decides it is right for you. Wegovy is authorised in the EU and can be prescribed after a medical review.
Our doctors review every Weight loss option and recommend what fits your history and goals.
See all Weight loss optionsEvery trial behind Wegovy is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Yes. People in Gijón, Spain, can request an online doctor consultation about Wegovy with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the electronic prescription arrives as a QR code that can be dispensed directly in Spain.
Availability
Wegovy is available to residents of Spain through the online consultation. A prescription follows only if the doctor approves it.
How the EU prescription works where you are: In Spain, an approved prescription arrives electronically with a QR code for direct dispensing.
VERIFIED EVIDENCE
Wegovy contains semaglutide, an EU-authorised prescription medicine. The data below separate its regulatory status from the pivotal trial result.
WHAT IT IS
Semaglutide is a once-weekly agonist that activates the GLP-1 receptor.
DEVELOPMENT STAGE
The EMA marketing authorisation has been valid across the EU since 6 January 2022 under EMEA/H/C/005422.
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| STEP 1NCT03548935 | Obesity or overweight without diabetes | 1,961 | Read out | 2021 |
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| Semaglutide 2.4 mg | −14.9% | 68 |
| Placebo | −2.4% | 68 |
Peer-reviewed STEP 1, N=1,961, 68 weeks. Adults with type 2 diabetes were excluded.
Last reviewed 2026-07-27
About
Active ingredient: Semaglutide · Dosages: 0.25 – 2.4 mg / week
Semaglutide is a GLP-1 receptor agonist — a medication that mimics a natural hormone your gut releases after eating. It reduces appetite, slows gastric emptying and helps maintain sustained weight loss when combined with supervised nutrition and activity changes.
It's prescribed alongside changes to diet and activity, as part of a medically supervised plan — not on its own, and not as a shortcut. A licensed EU doctor decides whether it's appropriate and safe for you.
How it helps
Acts on hunger signals, so many people feel satisfied with less food.
Food stays in your stomach longer, so you tend to feel full for longer.
Prescribed alongside support for diet and activity — never as a standalone fix.
What to expect
The dose is increased slowly over 16 weeks to help your body adjust and to ease side effects. Your doctor sets your exact schedule.
Typical escalation
Safety first
Wegovy is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Adults with obesity (BMI ≥30) or with overweight (BMI ≥27) plus at least one weight-related condition such as type 2 diabetes, hypertension or dyslipidaemia.
Who should not take it
PRICING
€25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth. One-off consultations are €35 for sexual health and €40 for dermatology.
ONGOING PLAN
€25/month
Billed €25 every 28 days · cancel anytime
28-day treatment cycle
For ongoing treatment and doctor-reviewed renewals.
Renewals reviewed by your doctor
Full refund if a review is not approved
WHAT'S INCLUDED
Full refund if a review is not approved
If a review is not approved, we refund that period's €25 fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
An EU-licensed doctor reads your questionnaire and answers in less than 2 hours on average.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
OTHER WEIGHT LOSS TREATMENTS
Find out if it's right for you
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.
HI-DOCTOR NEWSLETTER
At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.